Inflation rebates to reduce Medicare payment for 34 Part B drugs
4.9 (203) · $ 28.00 · In stock
This October through December under the Inflation Reduction Act, Medicare will reduce the beneficiary coinsurance amount for 34 Part B prescription drugs between $1 and $618 per average dose, the Centers for Medicare & Medicaid Services announced recently.
Action Needed To Reduce Financial Incentives To Prescribe 340B
Comments to CMS Guidance on the Medicare Prescription Drug
Inflation Reduction Act contains 'unprecedented' health care
CMS Releases Guidance on the Medicare Prescription Drug Inflation
Injecting Price Competition into Medicare Part B Drugs-Mon, 07/26
Inflation Reduction Act of 2022: impacts Medicare Part B drugs
CEI Joins ATR Led Drug Price Control Coalition Letter
A Comparison of Brand-Name Drug Prices Among Selected Federal
IRA Provisions on Drug Pricing
News ASHRM
Special Report: Inflation Reduction Act Sets Part D Stakeholders
